Treating hyperglycemia with 25-hydroxyvitamin D3

Details for Australian Patent Application No. 2009214053 (hide)

Owner DSM IP Assets B.V.

Inventors Leuenberger, Bruno H.; Claerhout, Wouter; Buck, Neil Robert; Wolfram, Swen; Urban, Kai; Stoecklin, Elisabeth

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009214053

PCT Pub. Number WO2009/101136

Priority 61/028,510 13.02.08 US; 61/031,671 26.02.08 US; 61/036,927 14.03.08 US; 61/036,928 15.03.08 US

Filing date 12 February 2009

Wipo publication date 20 August 2009

International Classifications

A61K 31/593 (2006.01)

A61P 3/08 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

2 September 2010 PCT application entered the National Phase

  PCT publication WO2009/101136 Priority application(s): WO2009/101136

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009214054-Use of 25-hydroxy-vitamin D3 to affect human muscle physiology

2009214052-Combined use of 25-hydroxy-vitamin D3 and vitamin D3 for improving bone mineral density and for treating osteoporosis